Advertisement

Picture Berlin Partner HealthCapital Bionnale 2019 Germany May 650x80px

News > All

Total search results: 17111 | Ordered by Source (ascending)
next pagenext page 1 2 3 ... 167 168 169 ... 170 171 172  next pagenext page

order ascendingorder descendingSource order ascendingorder descendingDate
VeroVaccines GmbH. (7/17/17). "Press Release: VeroVaccines GmbH Founded in Halle (Saale), Germany". 2017-07-17
Versant Ventures. (12/17/18). "Press Release: Versant Ventures Raises $700 Million". San Francisco, CA, New York, NY & Vancouver, BC. 2018-12-17
Versantis AG. (3/29/17). "Press Release: Versantis Raises CHF 4.4 Million in Series A Financing to Advance New Generation of Liver Disease Medicines". Zurich. 2017-03-29
Versantis AG. (9/18/19). "Press Release: Versantis Closes CHF 16M Series B Financing Round to Advance Clinical Development of Novel Therapeutics for Liver Diseases". Zürich. 2019-09-18
Vertex Pharmaceuticals Inc.. (12/19/12). "Press Release: NHS in England Funds Kalydeco (ivacaftor), the First Medicine to Treat the Underlying Cause of Cystic Fibrosis, for People with a Specific Genetic Mutation (G551D)". Cambridge, MA. 2012-12-19
Vertex Pharmaceuticals Inc.. (6/6/19). "Press Release: Vertex Expands into New Disease Areas and Enhances Gene Editing Capabilities Through Expanded Collaboration with CRISPR Therapeutics and Acquisition of Exonics Therapeutics". Boston, MA & Watertown, 2019-06-06
Vesalius Biocapital Partners Sàrl. (5/18/17). "Press Release: Vesalius Biocapital Announces First Close of Its Third Fund". Bertrange. 2017-05-18
Vesalius Biocapital Partners Sàrl. (6/25/19). "Press Release: Vesalius Biocapital III Announces Final Close of EUR 120 Million Fund". Strassen, Luxembourg. 2019-06-25
Vessix Vascular, Inc-. (8/3/11). "Press Release: $23 Million Financing Complete and Corporate Name Changed to Vessix Vascular. Round Led by Edmond de Rothschild Investment and OrbiMed Advisors". Laguna Hills, CA. 2011-08-03
Vetter Pharma International GmbH. (11/9/17). "Press Release: Vetter Expands Its Footprint in Asia Pacific Region. Company Establishes Its Presence in South Korea". Songdo & Ravensburg. 2017-11-09
Vexim S.A.. (4/15/14). "Press Release: Vexim Doubles Its Sales in the 1st Quarter of 2014, to €2.1m". Toulouse. 2014-04-15
Vexim S.A.. (9/22/14). "Press Release: Vexim Announces Strong 2014 Half-year Results". Toulouse. 2014-09-22
Vexim S.A.. (9/8/14). "Press Release: Vexim Opens U.S. Subsidiary. Office to Support Vexim’s Product Portfolio Launch in the U.S.". Toulouse. 2014-09-08
Via Campesina, La. (4/4/12). "Press Release: Opposition to Biotech Giant Monsanto Growing Worldwide, New Report Shows". Washington, DC, Montevideo & Paris. 2012-04-04
VIB / Ghent University. (8/11/10). "Press Release: VIB and UGent Researchers Identify Key Mechanims of Cell Division of Plants. New Technology Can Be Applied to Boost Crop Yields". Ghent. 2010-08-11
VIB, Flanders Interuniversity Institute of Biotechnology. (12/1/16). "Press Release: V-Bio Ventures Closes First Life Sciences Fund, Raising over € 75 Million". 2016-12-01
VIB, Flanders Interuniversity Institute of Biotechnology. (12/11/17). "Press Release: New VIB Start-up Aelin Therapeutics Secures 27m € to Exploit Its Proprietary Pept-in Protein Knockdown Platform". 2017-12-11
VIB, Flanders Interuniversity Institute of Biotechnology. (3/24/17). "Press Release: VIB and DNAlytics Team Up to Develop Non-invasive Colorectal Cancer Screening Test". 2017-03-24
VIB, Flanders Interuniversity Institute of Biotechnology. (8/27/14). "Press Release: Nature Biotechnology Article Describes New Dutch Technology that Improves DNA Sequencing". 2014-08-27
Vibalogics GmbH. (5/29/19). "Press Release: Ampersand Capital Partners to Acquire Vibalogics GmbH". Cuxhaven & Wellesley, MA. 2019-05-29
Vida Ventures. (8/1/19). "Press Release: Vida Ventures Closes $600 Million Vida II Fund to Support Life Science Innovation". Boston, MA. 2019-08-01
Vifor Pharma AG. (2/14/17). "Press Release: Vifor Pharma and ChemoCentryx Announce Expansion of Avacopan Agreement for Rare Renal Diseases". 2017-02-14
Vifor Pharma AG. (5/23/18). "Press Release: VFMCRP and Cara Therapeutics to Develop and Commercialise CR845 Injection for Chronic Kidney Disease-associated Pruritus". 2018-05-23
Vifor Pharma AG. (7/21/17). "Press Release: European Commission Approves Marketing Authorisation for Veltassa". 2017-07-21
ViGeneron GmbH. (11/28/19). "Press Release: ViGeneron Announces Closing of Series A Financing to Drive Development of Next Generation Gene Therapy Pipeline". Munich. 2019-11-28
Vir Biotechnology, Inc.. (10/18/17). "Press Release: Vir Biotechnology Builds Pipeline, Capabilities, and Lays Out Strategy to Address Serious Infectious Diseases". San Francisco, CA. 2017-10-18
ViraTherapeutics GmbH. (3/5/18). "Press Release: ViraTherapeutics Starts Second Oncolytic Virus Development Program with Boehringer Ingelheim". Innsbruck. 2018-03-05
ViraTherapeutics GmbH. (5/30/17). "Press Release: ViraTherapeutics Appoints Heinz Schwer as CEO". Innsbruck. 2017-05-30
ViraTherapeutics GmbH. (6/23/15). "Press Release: ViraTherapeutics Raises €3.6 million in the First Closing of a Series A Financing Round to Advance Its Novel Oncolytic Virus Platform". Innsbruck. 2015-06-23
ViraTherapeutics GmbH. (9/13/18). "Press Release: Boehringer Ingelheim Acquires All ViraTherapeutics Shares to Develop Next Generation Viral-Based Immuno-Oncology Therapies". Ingelheim. 2018-09-13
Virion Biotherapeutics Ltd.. (11/14/18). "Press Release: Virion Biotherapeutics Demonstrates Preclinical Proof-of-Concept for First Therapeutic Interfering Particle Candidate in Respiratory Virus Infections". London. 2018-11-14
Virion Biotherapeutics Ltd.. (12/17/18). "Press Release: Virion Biotherapeutics Appoints Edwin Moses as Chairman of the Board and Guido Dietrich as Head of Manufacturing". London. 2018-12-17
Virion Biotherapeutics Ltd.. (9/17/18). "Press Release: Virion Appoints Vanessa King as President & CEO and Isabel Najera as CSO". London. 2018-09-17
VirionHealth Ltd.. (10/12/17). "Press Release: VirionHealth Raises Series A Funding from Abingworth". 2017-10-12
ViroPharma Inc.. (10/27/11). "Press Release: ViroPharma to Acquire DuoCort Pharma AB, Adding Important European Orphan Drug to Commercial Pipeline". Exton, PA. 2011-10-27
ViroPharma Inc.. (11/15/11). "Press Release: ViroPharma Completes Acquisition of DuoCort Pharma AB". Exton, PA. 2011-11-15
ViroVet BVBA. (9/15/15). "Press Release: ViroVet Commences Operations. New Animal Health Company Focused on Livestock". Leuven. 2015-09-15
ViroVet N.V.. (1/10/17). "Press Release: ViroVet Successfully Raises €5 Million in Series A Funding". 2017-01-10
ViroVet N.V.. (1/27/17). "Press Release: Dr George Gunn, Former CEO of Novartis Animal Health, Appointed as Chairman at ViroVet". Leuven. 2017-01-27
ViruSure GmbH. (11/21/12). "Press Release: Sekisui Medical, Japan, and ViruSure Agree Marketing Cooperation in Japan. Offering Biosafety Testing Expertise for Japan’s Biopharmaceutical Companies". Tokyo. 2012-11-21
Visiopharm A/S. (7/13/18). "Press Release: Visiopharm Releases Version 2018.4 of VIS Image Analysis Software – Adding More User-Friendly Functionalities". 2018-07-13
Visiopharm A/S. (8/24/18). "Press Release: Strong Consortium Invests Nearly DKK 100 million (€ 13.3 million) into Danish Image Analysis Leader, Visiopharm A/S". 2018-08-24
Visiopharm A/S. (9/7/18). "Press Release: Launching Phenomap Multiplexing". 2018-09-07
Vita 34 AG. (2/8/19). "Press Release: Vita 34 Develops Cell Preparations as the Source Material for Immune Cell Therapies and Becomes Cell Bank". Leipzig. 2019-02-08
Vita 34 AG. (4/20/17). "Press Release: Vita 34 Concludes Purchase Agreement for the Entire Acquisition of Its Competitor Seracell Pharma AG". Leipzig. 2017-04-20
Vita 34 AG. (5/16/12). "Press Release: Vita 34 Strengthens Biotechnology Sector by Company Takeover and Announces Change in Management Board". Leipzig. 2012-05-16
VitamFero S.A.. (9/30/14). "Press Release: VitamFero Successfully Secures Its Third Round of Financing". 2014-09-30
VitriCell S.A.. (1/23/18). "Press Release: VitriCell Raises Over €1 Million ($1.2M) in Series A Funding". Liège. 2018-01-23
Vivalis S.A.. (1/17/12). "Press Release: Vivalis and Sanofi Pasteur Extend Their 2010 Collaboration and License Contract with a New Human Monoclonal Antibody Discovery Target against a New Infectious Disease". Nantes, Lyon & Toyama. 2012-01-17
Vivalis S.A.. (1/23/12). "Press Release: Opening of a New Laboratory Dedicated to the Viva|Screen Antibody Discovery Platform". Nantes, Lyon & Toyama. 2012-01-23
Vivalis S.A.. (1/24/12). "Press Release: Strong Revenue Growth – +112%. Initation of a Third Antibody Discovery Program with Sanofi Pasteur". Nantes & Lyon. 2012-01-24
Vivalis S.A.. (12/16/12). "Press Release: Proposed Merger of Equals between Vivalis and Intercell. Creation of a European Biotech Leader in Vaccines and Antibodies [Not for Distribution in Australia, Canada, Japan or the United States]". Nantes & Vienna. 2012-12-16
Vivalis S.A.. (2/14/13). "Press Release: 2012 – A Record Year for New EB66 Cell Line Licensing". Nantes. 2013-02-14
Vivalis S.A.. (3/13/12). "Press Release: Vivalis Announces the Signature of a Broad Collaboration Agreement and Commercial License for the Use of the EB66 Cell Line for the Production of a Monoclonal Antibody". Nantes & Lyon. 2012-03-13
Vivalis S.A.. (3/26/13). "Press Release: Consolidated 2012 Financial Results". Nantes & Lyon. 2013-03-26
Vivalis S.A.. (3/26/13). "Press Release: The Expanded Development of EB66 Cell Line as Part of the GlaxoSmithKline (GSK) – Texas A&M University System Influenza Vaccine Program in the United States". Nantes & Lyon. 2013-03-26
Vivalis S.A.. (3/29/12). "Press Release: Vivalis 2011 Results. Continuing Growth Momentum". Nantes & Lyon. 2012-03-29
Vivalis S.A.. (3/7/13). "Press Release: Vivalis SA and Intercell AG Shareholders Approved the Proposed Merger of Equals to Create Valneva SE". Nantes & Vienna. 2013-03-07
Vivalis S.A.. (4/8/13). "Press Release: Vivalis Announces a New EB66 Cell Line Research Services and License Option Agreement with GlaxoSmithKline". 2013-04-08
Vivalis S.A.. (6/20/12). "Press Release: Vivalis Announces a New EB66 Cell Line Commercial License Agreement with Farvet Farmacológicos Veterinarios". 2012-06-20
Vivalis S.A.. (8/21/12). "Press Release: Successful Growth of BioDiem’s Virus in Vivalis EB66 Cell Line". Melbourne & Nantes. 2012-08-21
Vivalis S.A.. (8/28/12). "Press Release: Vivalis Announces a New EB66 Cell Line Research License Agreement with BioFactura". Nantes & Lyon. 2012-08-28
Vivasure Medical Ltd.. (9/8/16). "Press Release: Vivasure Medical Announces €16.2M ($18.3M) in Financing to Advance Commercialization of Closure Device in European Union and United States". Galway. 2016-09-08
Vivet Therapeutics S.A.S.. (3/20/19). "Press Release: Pfizer Secures Exclusive Option to Acquire Gene Therapy Company Vivet Therapeutics". Paris & New York, NY. 2019-03-20
Vivet Therapeutics S.A.S.. (5/4/17). "Press Release: Vivet Therapeutics Raises €37.5 Million in Series A Financing Round to Advance Novel Gene Therapies for Treating Inherited Metabolic Diseases". Paris. 2017-05-04
Vivet Therapeutics S.A.S.. (6/12/18). "Press Release: Vivet Therapeutics Appoints Eduardo Bravo as New Chairman of the Board". Paris. 2018-06-12
Vivoryon Therapeutics AG. (1/14/20). "Press Release: Vivoryon Therapeutics and Nordic Bioscience Enter Research and Development Collaboration". Halle (Saale) & Herlev. 2020-01-14
Vivoryon Therapeutics AG. (10/8/19). "Press Release: Vivoryon Therapeutics AG Launches Rights Offering to Fund its Phase 2b Clinical Development Program in Alzheimer’s Disease with Strong Commitments [Not for US, et al.]". Halle (Saale). 2019-10-08
Vivoryon Therapeutics AG. (8/29/19). "Press Release: Vivoryon Therapeutics Reports Financial Results for H1 2019 and Corporate Update". Halle (Saale). 2019-08-29
Vlerick Business School. (2/23/17). "Press Release: Vlerick and KU Leuven Found the Health Sciences & Business Institute Together". 2017-02-23
Voyager Therapeutics, Inc.. (1/22/19). "Press Release: Voyager Therapeutics Appoints Robert Hesslein as General Counsel". Cambridge, MA. 2019-01-22
Voyager Therapeutics, Inc.. (6/28/18). "Press Release: Voyager Therapeutics Appoints Andre Turenne as President and Chief Executive Officer". Cambridge, MA. 2018-06-28
VTT Technical Research Centre of Finland. (10/26/11). "Press Release: VTT and the MSI Combine Their Unique Competencies to a New Center for Bioengineering. Opening of the New Center on 25th 2011 in Berkeley, California". 2011-10-26
VTU Technology GmbH. (12/3/14). "Press Release: VTU Technology and RCT Announce Partnership". Tucson, AZ & Grambach. 2014-12-03
VTU Technology GmbH. (2/10/15). "Press Release: Boehringer Ingelheim Renews Global Technology Collaboration Agreement with VTU Technology". Vienna & Grambach. 2015-02-10
VTU Technology GmbH. (4/27/16). "Press Release: VTU Technology and Boehringer Ingelheim Strengthen Their Global Microbial Technology Collaboration". Grambach & Vienna. 2016-04-27
VTU Technology GmbH. (5/20/15). "Press Release: VTU Technology and Biomay Have Signed License Agreement. Biomay to Apply VTU Pichia Strains for the Production of Recombinant Allergens". Grambach & Vienna. 2015-05-20
VUV Analytics, Inc.. (6/7/16). "Press Release: VUV Analytics Launches Next Generation Gas Chromatography Detector. VGA-101 Presents the Latest Innovation in Vacuum Ultraviolet Spectroscopy". Austin, TX. 2016-06-07
VWR International, LLC. (4/3/12). "Press Release: VWR International, LLC Acquires Vitrum Praha s.r.o. and Vitrum Roznov s.r.o. in the Czech Republic". Radnor, PA. 2012-04-03
VWR International, LLC. (9/2/11). "Press Release: VWR International, LLC Acquires International P.B.I. S.p.A. – VWR Strengthens Its Position in Italy". Radnor, PA. 2011-09-02
Vygon S.A.. (9/2/14). "Press Release: Vygon Group Buys Medwin". Ecouen. 2014-09-02
Wacker Chemie AG. (2/2/16). "Press Release: Wacker Lifts Sales in 2015 above €5 Billion for the First Time and Increases Its Net Income". Munich. 2016-02-02
Wacker Chemie AG. (3/8/17). "Press Release: Wacker Biotech and Fresenius Medical Care Successfully Produce Antibody Fragment with Foldtec". Munic & Jena. 2017-03-08
Wacker Chemie AG. (9/13/18). "Press Release: Wacker Invests in Jena Biotech Site". Jena. 2018-09-13
Wallinger Ricker Schlotter Tostmann (WRST). (8/25/14). "Pressemitteilung: BGH bestätigt Gradientencycler-Patent. Vertreten durch die Kanzlei Wallinger Ricker Schlotter Tostmann (WRST) stärkt die Eppendorf AG ihre Patentposition". München. 2014-08-25
Warp Drive Bio, Inc.. (10/16/17). "Press Release: Warp Drive Bio Forms Strategic Collaboration to Advance Novel Classes of Antibiotics to Combat Multi-Drug-Resistant Bacterial Infections". Cambridge, MA. 2017-10-16
Warp Drive Bio, Inc.. (11/29/16). "Press Release: Warp Drive Bio Achieves Key Milestone in Antibiotics Collaboration with Sanofi". Cambridge, MA. 2016-11-29
Waters Corporation. (1/13/20). "Press Release: Waters to Acquire Andrew Alliance". Milford, MA. 2020-01-13
Waters Corporation. (1/15/15). "Press Release: The Waters ionKey/MS Technology Named a Top Innovation for 2014. First Microfluidic Device for MicroScale Chromatography to Receive Analytical Scientist Magazine Innovation Award". Milford, MA. 2015-01-15
Waters Corporation. (1/16/18). "Press Release: Waters and Malvern Panalytical Collaborate to Improve Polymer Characterization". Milford, MA. 2018-01-16
Waters Corporation. (1/17/12). "Press Release: Waters and Tecan Sign Agreement for Clinical Assay Platform. Enabling Better, More Efficient and Higher Throuphput Clinical LC/MS Assays". San Diego, CA. 2012-01-17
Waters Corporation. (1/20/11). "Press Release: Waters to Build New Mass Spectrometry Headquarters near Manchester, U.K. New Facility Will Combine World-class Customer Demonstration Labs with Advanced R&D and Expanded Manufacturing Capacity". Manchester. 2011-01-20
Waters Corporation. (1/20/12). "Press Release: Waters and NIBRT Complete Work on World’s First UPLC Glycan Database. Bringing More Accuracy and Efficiency to Protein Glycosylation Assessment and Greater Predictability to Biopharmaceutical Processing". Mi 2012-01-20
Waters Corporation. (1/22/13). "Press Release: Fera and Waters Open International Food Safety Training Laboratory". York. 2013-01-22
Waters Corporation. (1/22/13). "Press Release: Waters Reports Fourth Quarter 2012 Financial Results". Milford, MA. 2013-01-22
Waters Corporation. (1/4/17). "Press Release: Waters CE-Marks In Vitro Diagnostic MassTrak Vitamin D Solution". Milford, MA. 2017-01-04
Waters Corporation. (1/5/16). "Press Release: Waters Acquity UPLC I-Class/Xevo TQ-S micro System Available as a U.S. FDA Class I, CE-marked Medical Device". Milford, MA. 2016-01-05
Waters Corporation. (1/6/16). "Press Release: Waters and BioCity to Establish an Open Access Analytical Laboratory in the BioHub at Alderley Park, UK". Milford, MA. 2016-01-06
Waters Corporation. (10/5/11). "Press Release: Waters Empowers Advantar Laboratories for Sustained Growth". Milford, MA. 2011-10-05
Waters Corporation. (10/7/13). "Press Release: Waters Introduces the ACQUITY QDa Detector, Bringing Push-button Mass Detection to Chromatography". Milford, MA. 2013-10-07
next pagenext page 1 2 3 ... 167 168 169 ... 170 171 172  next pagenext page



Advertisement

Picture Kentro Design Corporate and Web Design Berlin 650x65px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]


Advertisement

Picture ConsulTech GmbH Berlin Grant Application and Coordination 650x80px

» top